| 000 | 01629 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517052449.0 | ||
| 264 | 0 | _c20160606 | |
| 008 | 201606s 0 0 eng d | ||
| 022 | _a1872-8227 | ||
| 024 | 7 |
_a10.1016/j.diabres.2015.08.007 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYokoyama, H | |
| 245 | 0 | 0 |
_aPrevalence of resistant hypertension and associated factors in Japanese subjects with type 2 diabetes. _h[electronic resource] |
| 260 |
_bDiabetes research and clinical practice _cOct 2015 |
||
| 300 |
_a18-25 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAlbuminuria _xepidemiology |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBlood Pressure _xphysiology |
| 650 | 0 | 4 | _aCross-Sectional Studies |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xepidemiology |
| 650 | 0 | 4 | _aDrug Resistance |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGlomerular Filtration Rate |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xdrug therapy |
| 650 | 0 | 4 |
_aJapan _xepidemiology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aAraki, S | |
| 700 | 1 | _aWatanabe, S | |
| 700 | 1 | _aHonjo, J | |
| 700 | 1 | _aOkizaki, S | |
| 700 | 1 | _aYamada, D | |
| 700 | 1 | _aShudo, R | |
| 700 | 1 | _aShimizu, H | |
| 700 | 1 | _aSone, H | |
| 700 | 1 | _aHaneda, M | |
| 773 | 0 |
_tDiabetes research and clinical practice _gvol. 110 _gno. 1 _gp. 18-25 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.diabres.2015.08.007 _zAvailable from publisher's website |
| 999 |
_c25253353 _d25253353 |
||